Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 247

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery

Z. Konakci, K., Bohle, B., Blumer, R., Hoetzenecker, W., Roth, G., Moser, B., Boltz‐Nitulescu, G., Gorlitzer, M., Klepetko, W., Wolner, E., Ankersmit, H. J.·2005·European Journal of Clinical Investigation

Abstract

Background The α‐Gal (Galα1,3‐Galβ1–4GlcNAc‐R) epitope is the major xenoantigen causing hyperacute rejection of pig organs transplanted into primates. Porcine bioprostheses are utilized in cardiac surgery. However, premature degeneration of bioprostheses has limited utilization in younger patients and the immune response remains elusive. We sought to investigate whether a specific α‐Gal immune response may play a role in this clinical scenario. Materials and methods We investigated the presence of α‐Gal‐epitope on native and fixed porcine valves by means of confocal laser scanning microscope (CLSM). ELISA was utilized to evidence whether implantation of bioprostheses elicits augmentation of pre‐existing cytotoxic anti α‐Gal IgM antibodies within 10 days of surgery. Patients who underwent coronary artery bypass grafting (CABG) or mechanical valve replacement served as controls (each group, n = 12). To corroborate the clinical relevance of the α‐Gal immune response in vivo, we studied serum obtained before and after implantation of bioprostheses and its potency to lyse porcine α‐Gal‐bearing PK15 cells. Results We found the immunogenic α‐Gal‐epitope on fibrocytes interspersed in the connective tissue of porcine valves as determined by vimentin/IB4 lectin binding. Moreover, patients who were provided with a bioprostheses had developed a significant increase of naturally occurring cytotoxic IgM antibodies directed towards α‐Gal after surgical intervention as compared with control patients (P < 0·0001, respectively). Sera obtained from the patients after the implantation of bioprostheses demonstrated an increased cytotoxicity against α‐Gal‐bearing PK‐15 cells as compared with preoperative sera (P < 0·001). The specificity of the cytotoxic effects was proven as soluble Galα1–3Galβ1–4GlcNAc markedly inhibited cell death of α‐Gal‐bearing PK15 cells (P < 0·001). Conclusion Our data suggest that implantation of bioprostheses in cardiac surgery induces a xenograft‐specific immune response. Procedures diminishing the presence of α‐Gal on bioprostheses, such as utilization of genetically manipulated α‐Gal‐deficient xenograft or pretreatment with α‐Galactosidase, might diminuate the immune response against bioprostheses and extend durability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2005.01441.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 247

Metadata

Authors
Z. Konakci, K., Bohle, B., Blumer, R., Hoetzenecker, W., Roth, G., Moser, B., Boltz‐Nitulescu, G., Gorlitzer, M., Klepetko, W., Wolner, E., & Ankersmit, H. J.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2005-01
Volume
35
Issue
1
Pages
17-23
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2090303367
Cited by
247
References
1
FWCI
4.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery. https://app.cochat.ai/papers/10.1111/j.1365-2362.2005.01441.x
The paper
Z. Konakci, K., Bohle, B., Blumer, R., Hoetzenecker, W., Roth, G., Moser, B., Boltz‐Nitulescu, G., Gorlitzer, M., Klepetko, W., Wolner, E., & Ankersmit, H. J. (2005). Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2005.01441.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.